Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
This stability is unusual among peptide research compounds and allows investigators to use BPC-157 in both oral and parenteral administration designs in pre-clinical models
GHK-Cu concurrently down-regulates NF-kB activity and reduces oxidative stress markers in macrophage cultures
The cancelled Phase I trial was not buried by a regulator
During the last 20 years, there has been limited research on BPC-157 (2)
Each vial provides about 10 days of dosing at 500 mcg/day or about 16-17 days at 300 mcg/day after reconstitution
US$ 28.65
US$ 24.15
US$ 25.64
US$ 26.05
